Renaissance Technologies
AVNS

Renaissance Technologies’s Avanos Medical AVNS Stock Holding History

Renaissance Technologies’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.37M Buy
+256,100
New +$6M 0.01% 1316
2025
Q4 		– Sell
-78,500
Closed -$907K – 3233
2025
Q3 		$907K Sell
78,500
-18,300
-19% -$214K ﹤0.01% 2533
2025
Q2 		$1.18M Buy
96,800
+79,900
+473% +$1M ﹤0.01% 2414
2025
Q1 		$242K Buy
+16,900
New +$264K ﹤0.01% 3004
2023
Q4 		– Sell
-59,868
Closed -$1.21M – 3727
2023
Q3 		$1.21M Buy
59,868
+41,668
+229% +$945K ﹤0.01% 2170
2023
Q2 		$465K Sell
18,200
-14,300
-44% -$377K ﹤0.01% 2910
2023
Q1 		$967K Buy
32,500
+10,900
+50% +$316K ﹤0.01% 2499
2022
Q4 		$584K Buy
+21,600
New +$528K ﹤0.01% 2865
2022
Q3 		– Sell
-8,800
Closed -$241K – 4013
2022
Q2 		$241K Sell
8,800
-3,000
-25% -$86.2K ﹤0.01% 3568
2022
Q1 		$395K Buy
+11,800
New +$380K ﹤0.01% 3332
2021
Q4 		– Sell
-132,300
Closed -$4.13M – 3888
2021
Q3 		$4.13M Buy
132,300
+44,500
+51% +$1.51M 0.01% 1590
2021
Q2 		$3.19M Buy
+87,800
New +$3.63M ﹤0.01% 1925
2020
Q3 		– Sell
-72,800
Closed -$2.14M – 3366
2020
Q2 		$2.14M Buy
+72,800
New +$2.11M ﹤0.01% 2151
2018
Q4 		– Sell
-140,700
Closed -$9.64M – 3371
2018
Q3 		$9.64M Sell
140,700
-177,100
-56% -$11.4M 0.01% 1387
2018
Q2 		$18.2M Buy
317,800
+85,600
+37% +$4.52M 0.02% 979
2018
Q1 		$10.7M Buy
232,200
+222,395
+2,268% +$10.6M 0.01% 1321
2017
Q4 		$453K Buy
+9,805
New +$451K ﹤0.01% 2909
2017
Q3 		– Sell
-46,300
Closed -$1.82M – 3196
2017
Q2 		$1.82M Buy
46,300
+27,221
+143% +$1.03M ﹤0.01% 2307
2017
Q1 		$727K Buy
+19,079
New +$743K ﹤0.01% 2652
2016
Q4 		– Sell
-93,300
Closed -$3.23M – 3239
2016
Q3 		$3.23M Buy
93,300
+68,200
+272% +$2.39M 0.01% 1899
2016
Q2 		$816K Buy
+25,100
New +$769K ﹤0.01% 2614
2015
Q3 		– Sell
-121,600
Closed -$4.92M – 3154
2015
Q2 		$4.92M Buy
+121,600
New +$5.46M 0.01% 1443

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Renaissance Technologies's AVNS Position: Q2 2026 in Review

Renaissance Technologies opened a new position in Avanos Medical (AVNS) in Q2 2026: 256,100 shares worth $6.37M. The stake represents 0.01% of the portfolio and ranks #1316 among its holdings. This is a return to the name: Renaissance Technologies previously reported a position in AVNS as recently as Q3 2025.

Renaissance Technologies first reported a position in AVNS in Q2 2015 and has held it in 22 quarters since. The position peaked at $18.2M in Q2 2018. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Renaissance Technologies held 256,100 shares of Avanos Medical worth $6.37M as of Q2 2026.
  • Avanos Medical was a new Renaissance Technologies position in Q2 2026.
  • Avanos Medical made up 0.01% of Renaissance Technologies's portfolio in Q2 2026, its #1316 holding.
  • Renaissance Technologies first reported a position in Avanos Medical in Q2 2015 and has held it in 22 quarters since.
  • Renaissance Technologies's Avanos Medical position peaked at $18.2M in Q2 2018.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.